Lovas, S. et al. 2025. Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients – Real World Data from Hungary. Journal of Hematology. 14, 6 (Jan. 2025), 314–323. DOI:https://doi.org/10.14740/jh2142.